Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Entero Healthcare Solutions has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 14, 2024 to consider, approve and take on record the standalone and consolidated audited financial results of the Company for the quarter ended June 30, 2024. As informed vide its letter dated June 27, 2024, the trading window for dealing in the securities of the Company that was closed for all designated persons, fiduciaries, connected persons and their immediate relatives from June 27, 2024, shall continue to remain closed till completion of 48 hours after the declaration of financial results on the portal of the Stock Exchange(s).
The above information is a part of company’s filings submitted to BSE.
